MRI Yields Most Concordant Breast Cancer Tumor Size Assessment

Magnetic resonance imaging (MRI) was found to provide the most concordant tumor size assessment among breast imaging techniques, although significant overestimation exists, according to research presented at the 17th St. Gallen International Breast Cancer Conference 2021.F.C. Pop, from the Jules Bordet Institute, Université Libre de Bruxelles, in Brussels, Belgium, and colleagues included 752 patients (mean […]

Read More

Treatment With Levonorgestrel-Dispensing IUD Appeared To Be Effective, Safe For Women With Stage I Endometrial Adenocarcinoma Or Endometrial Hyperplasia With Atypia

Healio  (3/26, Lawrence) reported, “Treatment with a levonorgestrel-dispensing intrauterine device appeared to be effective and safe for women with stage I endometrial adenocarcinoma or endometrial hyperplasia with atypia, according to results of a randomized, phase 2 study.” The study results “showed two-thirds of women had no signs of cancer or precancer in biopsies 6 months after insertion […]

Read More

Women With Early Cervical Cancer Who Conceived At Least Three Months After Fertility-Sparing Surgery Had High Live Birth Rate

Healio (3/24, Leiser) reports, “Women with early cervical cancer who conceived at least 3 months after fertility-sparing surgery had a high live birth rate, according to results presented at” the Society of Gynecologic Oncology (SGO) 2021 Annual Meeting on Women’s Cancer. However, Healio says, “these women had elevated risks for preterm delivery and neonatal morbidity compared with […]

Read More

Rucaparib Significantly Improved PFS Compared With Chemo In Patients With BRCA-Mutated, Advanced, Relapsed Ovarian Cancer

MD Edge ObGyn  (3/21, Osterweil) reports, “The PARP inhibitor rucaparib significantly improved progression-free survival (PFS) compared with standard-of-care chemotherapy in women with BRCA-mutated, advanced, relapsed ovarian cancer in the phase 3 ARIEL4 study.” The findings from ARIEL4 were presented at the Society of Gynecologic Oncology (SGO) 2021 Annual Meeting on Women’s Cancer. MedPage Today  (3/20, Bankhead) reported, “Treatment with […]

Read More

Researchers Study Impact Of Delayed Or Cancelled Cancer Screenings Due To COVID-19 Pandemic

The AP (3/16, Marchione) reports, “Millions of colonoscopies, mammograms, lung scans, Pap tests and other cancer screenings were suspended for several months last spring in the United States and elsewhere as COVID-19 swamped medical care.” The AP adds, “Now researchers are studying the impact, looking to see how many cancers were missed and whether tumors found since then […]

Read More

Patients Consider Risk Of Menopause, Cancer When Making Ovarian Cancer Prevention Surgery Decisions

Medscape (3/5, Otto, Subscription Publication) reported, “Patients consider the risk of cancer and menopause, as well as other factors, when making decisions about ovarian cancer prevention surgery, according to a small study.” Researchers “interviewed 24 premenopausal women with BRCA mutations who were considering prophylactic surgery,” and “responses showed that women who prioritized cancer risk reduction opted for […]

Read More

Continuing Treatment With Bevacizumab Beyond Progression Improved PFS Compared With Chemo Alone For Patients With Recurrent Ovarian Cancer, Study Shows

Cancer Network (3/13, Fowler) reported, “Continuing treatment with bevacizumab (Avastin) beyond progression improved progression-free survival for patients with platinum-sensitive recurrent ovarian cancer compared with chemotherapy alone, according to data published in The Lancet Oncology.” The study results “sought to determine the value of continued bevacizumab treatment after progression following first-line treatment, suggesting this therapeutic path could be considered […]

Read More

Researchers Outline How Germline Genetic Testing Has Evolved Over Time In Women With Breast Or Ovarian Cancer

Medscape (3/8, Lyss, Subscription Publication) reports, “A large, retrospective study shows how germline genetic testing has evolved over time in women with breast or ovarian cancer and reveals a path forward for testing these patients.” The study’s authors “found racial and ethnic disparities in genetic testing as well as ‘persistent underuse’ of testing in patients with […]

Read More

COVID-19 Vaccines Shouldn’t Be Delayed In Patients With Cancer, Despite Potential For Clinically Evident Adenopathy On Imaging Following Vaccination

Reuters Health (3/3, Rapaport) reports, “Patients with cancer shouldn’t delay COVID-19 vaccination despite the potential for clinically evident adenopathy on imaging done after vaccination, according to recommendations from a multidisciplinary panel of scientific experts.” According to recommendations published in Radiology, “vaccination-associated adenopathy or axillary swelling may appear within two to four days after either vaccine dose and last up […]

Read More

FDA Authorizes Surgical Robot Designed For Transvaginal Hysterectomies

FierceBiotech (3/2, Hale) reports the FDA has “cleared its first surgical robot designed for transvaginal hysterectomies, a minimally invasive option that aims for a faster recovery time compared to procedures that require a larger abdominal incision.” FierceBiotech adds, “Memic Innovative Surgery’s Hominis system is intended to assist with the removal of the uterus, along with one or […]

Read More